The use of whey protein concentrate in management of chronic hepatitis C virus–a pilot study

G Elattar, Z Saleh, ELS Safinaz, A Farrag… - Archives of Medical …, 2010 - termedia.pl
G Elattar, Z Saleh, ELS Safinaz, A Farrag, M Zoheiry, A Hassanein, ELG Maged, S Shendy…
Archives of Medical Science, 2010termedia.pl
Results: There was a significant decrease in viral load and markers of active inflammation,
alanine aminotransferase (ALT) and aspartate aminotransferase (AST), while serum
albumin, total leucocyte counts and absolute neutrophil counts showed significant elevation
accompanied by improvement of neutrophil phagocytic activity after WPC supplementation
compared to pre-treated levels. The oral WPC supplementation was well tolerated without
any serious adverse events. Conclusions: Oral supplementation of WPC has promising …
Results: There was a significant decrease in viral load and markers of active inflammation, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), while serum albumin, total leucocyte counts and absolute neutrophil counts showed significant elevation accompanied by improvement of neutrophil phagocytic activity after WPC supplementation compared to pre-treated levels. The oral WPC supplementation was well tolerated without any serious adverse events.
Conclusions: Oral supplementation of WPC has promising results as a new therapeutic strategy against HCV and its sequelae by decreasing the viral load and active inflammation as well as improving the synthetic capacity of the liver and the phagocytic function of neutrophils, in these patients.
termedia.pl